Q: The 3rd q numbers came out.comments please.The stock still seems undervalued.
5i Research Answer:
EPS of $1.21 beat estimates of $1.19; sales of $179M beat estimates by 3%. EBITDA of $23.6M also beat by 3%. Sales rose 20.5%. Order backlog increased 11% sequentially and 40.3% year over year. Margins improved 2.4 points and US distribution again was strong. The quarter looks fine, though with the stock up so much expectations were already high. It remains in a strong financial position and remains quite cheap at 11X earnings.